Center For Prostate Cancer is categorized under Doctors in Indianapolis, IN .
Center For Prostate Cancer was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Lisa Keenan, Office Manager at the company’s single location by writing to 8902 North Meridian St # 104, Indianapolis, Indiana IN 46260 or by phoning (317) 853-4500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Center For Prostate Cancer |
| Contact Person: | Lisa Keenan, Office Manager |
| Address: | 8902 North Meridian St # 104, Indianapolis, Indiana 46260 |
| Phone Number: | (317) 853-4500 |
| Website Address: | urologyofindiana.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Center For Prostate Cancer was started in 0 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Lisa Keenan, Office Manager for inquiries that concern Center For Prostate Cancer by calling the company number (317) 853-4500, as your correspondence is most welcome. Additionally, the physical location of the single location of Center For Prostate Cancer can be found at the coordinates 39.917317,-86.157999 as well as the street address 8902 North Meridian St # 104 in Indianapolis, Indiana 46260.
For its online presence, you may visit Center For Prostate Cancer’s website at urologyofindiana.com and engage with its social media outlets through on Twitter and on Facebook.